top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Agents
Antiviral Agents
Autore Adamson Catherine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (386 p.)
Soggetto topico Biology, life sciences
Research and information: general
Soggetto non controllato acteoside
acute/latent infection
acyclovir
adoptive cell therapy
antipsychotic drug
antiviral
antiviral activity
antiviral agent
antiviral agents
antiviral drug
antiviral effect
antiviral inhibitor
antiviral strategies
branched peptides
brevilin A
Burkitt lymphoma cells
C-FRA
cathelicidins
central nervous system
chemical footprinting
Clerodendrum trichotomum
clozapine
combination antiretroviral therapy (cART)
congenital infection
coxsackievirus B4
CRISPR/Cas
cytomegalovirus
defensins
dried blood spots
dried plasma spots
drug discovery
endocytosis
enteroviruses
epigallocatechin gallate
Epstein-Barr virus
Ethiopia
flavivirus
flavonoids
fluoxetine
furin inhibitor
ganciclovir
genistein
ginsenoside Rg1
glycosphingolipids
HCMV vaccine
hemagglutinin (HA)
heparan sulfate
hepatitis C virus
hepcidins
herpes B virus
herpes viruses
herpesvirus
HIV
human antimicrobial peptides
human immunodeficiency virus
ie-1 gene
IE1
IE2
immediate-early
influenza A virus
influenza A virus (IAV)
Japanese encephalitis virus
latent infection
lectin
lipid biosynthesis
LUMS1
lytic gene expression
macacine herpesvirus-1
measles virus
microvirin
mutations
n/a
neural stem cells
NF-κB signaling pathway
non-immunogenic
NS5
nucleic acid-based therapeutic approach
nucleoside analogues
oleanane-type derivatives
orthohantavirus
pediatrics
PEI
persistent infection
phenyl-benzotriazoles
Plantago asiatica
polyethylenimine
Porcine circovirus type 2
porcine reproductive and respiratory syndrome virus
pre-treatment drug resistance
precursor membrane protein
pro-inflammatory factor
prodrugs
protein drugs
ProTides
PRRSV
quantitative real-time PCR
replication
resistance
Rev response element
ribozyme
RNA interference
RNA-dependent RNA polymerase
RSV
sesquiterpene lactone
SHAPE
small molecule
sphingolipids
Surveyor nuclease mutation detection assay
TALEN
therapeutic effects
therapeutic strategies
transferrins
treatments
tropism
viral entry
virion internalization
virus attachment
virus entry inhibitors
viruses
Zika virus
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557448703321
Adamson Catherine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (578 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ADAM17
adoptive T cell therapy
AKT
androgens
apoptosis
autoimmune disease
autosomal-dominant hyper IgE syndrome
Bone Marrow Failure Syndromes
breast cancer
cancer
cancer models
cancer progression
cancer-stem cell
CD38
CD4+ T cells
CD8+ T cells
cell cycle
cell hierarchy
chaperones
chemotherapy resistance
cirrhosis
colon cancer
companion animals
comparative oncology
cytokine
cytokine receptor signaling
dynamic programming
endoplasmic reticulum (ER) stress
epidermal growth factor receptor (EGF-R)
ERK1/2
escape mechanisms
gain-of-function mutation
glioblastoma
glioma
growth hormone insensitivity syndrome
heat shock proteins
hedging
hematopoietic cancers
hepatitis C virus (HCV)
hepatocellular carcinoma (HCC)
hepatocyte nuclear factor 4 alpha (HNF4A)
immune check point
immune suppression
immunosuppression
immunotherapy
inflammation
inflammation associated cancer
inflammatory hepatocellular adenomas
interleukin-6
JAK
JAK family of protein tyrosine kinases
JAK2 V617F
knockout
lipopolyplex
lung cancer
lymphocytes
lymphoma
M2 macrophages
melanoma
meta-analysis
metalloprotease
metastasis
microRNA-122 (miR-122)
mitochondria
MPN
mTOR
multiple myeloma
mutations
myeloid cells
myeloid leukemia
n/a
nanoparticle
neoplastic stem cells
NGS
NK cells
nuclear factor erythroid 2-related factor 2 (NRF2)
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
ovarian cancer
oxidative stress (OS)
PD-L1
PEI
pharmacological inhibitor
pharmacological inhibitors
polyethylenimine
post-decision state variable
prolactin
proliferation
prostate cancer
RHOA
risk management
S3I-1757
SH2 domain
shedding
signal transducer and activator of transcription
signal transducer and activator of transcription 3 (STAT3)
siRNA delivery
siRNA/RNAi
small-molecule inhibitors
solid cancers
stabilization
STAT
STAT transcription factors
STAT3
STAT3 inhibitor XIII
STAT5
STAT5 signaling
STAT5B signaling
stem/progenitor cells
stemness
T-cell large granular lymphocytic leukemia
T-cell leukemia
T-cell prolymphocytic leukemia
T-cells
T-PLL
targeted therapy
targeting
therapeutic targeting
therapy resistance
trans-signaling
transaction costs
tumor microenvironment
tumor necrosis factor alpha (TNFα)
tumor suppression
tumor-associated macrophages
tumor-immune cell interactions
tumorigenesis
tyrosine kinase 2
unfolded protein response (UPR)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui